Literature DB >> 3164083

Prostaglandin E2 depresses antigen-presenting cell function of peritoneal macrophages.

R N Stephan1, P J Conrad, M Saizawa, R E Dean, I H Chaudry.   

Abstract

Eicosanoids play a prominent role in trauma. Such mediators of inflammation negatively influence cell-mediated immunity (CMI). There is, however, no information available on the effect of eicosanoids on a critical event in CMI, i.e., antigen-presenting (AP) cell function of macrophages (M luminal diameter), a cellular process responsible for the activation of T and B lymphocytes. The aim of this study, therefore, was to examine the effect of prostaglandin E2 (PGE2) and thromboxane B2 (TXB2) on AP cell function of the peritoneal M luminal diameter. To study this, a T-helper-cell clone, D10.G4.1 was employed. This cell clone proliferates in the presence of Iak (Class II glycoprotein, MAC product) bearing M luminal diameter and specific antigen (conalbumin A) thus directly reflecting the AP capability of the M luminal diameter. Peritoneal M luminal diameter were harvested from B10.BR mice (H2k) and their AP was tested in vitro by incubating varying numbers of M luminal diameter with 2 X 10(4) D10.G4.1 cells/well and conalbumin (400 micrograms/ml) in the presence and absence of different concentrations of PGE2 or TXB2. Cultures were incubated for 72 hr, pulsed with [3H]-thymidine, and harvested. At concentrations of 10, 30, and 100 nM of PGE2, D10.G4.1 proliferations were 38, 35, and 20% of control, respectively (P less than 0.05 compared to control). TXB2 added at the above-mentioned concentrations did not suppress the proliferative response of D10. Thus, PGE2 but not TXB2 has a potent immunosuppressive effect on AP of peritoneal M luminal diameter.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3164083     DOI: 10.1016/0022-4804(88)90108-4

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

Review 1.  Nutritional aspects of immunosuppression in athletes.

Authors:  N C Bishop; A K Blannin; N P Walsh; P J Robson; M Gleeson
Journal:  Sports Med       Date:  1999-09       Impact factor: 11.136

2.  HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids.

Authors:  P Foley; F Kazazi; R Biti; T C Sorrell; A L Cunningham
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

Review 3.  Systemic and peritoneal host defense in peritonitis.

Authors:  N V Christou
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

4.  A role for prostaglandins in the suppression of cutaneous cellular immunity and tumour development in benzo(a)pyrene- but not dimethylbenz(a)anthracene-treated mice.

Authors:  J Andrews; G M Halliday; H K Muller
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

5.  Role of Ca2+ in prostaglandin E2-induced T-lymphocyte proliferative suppression in sepsis.

Authors:  M A Choudhry; S Ahmad; M M Sayeed
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

6.  Blockade of prostaglandin production increases cachectin synthesis and prevents depression of macrophage functions after hemorrhagic shock.

Authors:  W Ertel; M H Morrison; A Ayala; M M Perrin; I H Chaudry
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

7.  Inhibition of macrophage-induced, antigen-specific T-cell proliferation by poly I:C role of suppressor macrophages.

Authors:  D A Kirschmann; X He; D M Murasko
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

8.  Marek's Disease Virus Modulates T Cell Proliferation via Activation of Cyclooxygenase 2-Dependent Prostaglandin E2.

Authors:  Nitin Kamble; Angila Gurung; Benedikt B Kaufer; Ansar Ahmed Pathan; Shahriar Behboudi
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.